4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-20-033780
Chief Business Officer sold 75,000 shares at $35.22 ($2,641,410)
- Chief Business Officer acquired 75,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Parrish Jay Chief Business Officer | 2020-06-01 | Option exercise | +75,000 | $1.49 | $111,375 | 297,222 | D |
| Parrish Jay Chief Business Officer | 2020-06-01 | Sale | −75,000 | $35.22 | $2,641,410 | 222,222 | D |
| Derivatives | |||||||
| Parrish Jay Chief Business Officer | 2020-06-01 | Option exercise · Stock Option (Right to Buy) | −75,000 | 72,221 | D | ||
| Open-market sales · 75,000 sh · avg $35.22 · $2,641,410 | |||||||
Loading xslF345X03/doc4.xml…